See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Betaferon, Betaseron
Generic Name: Interferon beta-1b SubQ Injection
What is Interferon beta-1b SubQ Injection? Interferon beta-1b is a drug in the interferon family used to treat multiple sclerosis. It is administered by sub-cutaneous injection and has been shown to slow the advance of the affliction as well as reduce the frequency of attacks.
See more information, including instructions, precautions, side effects, and interactions.
527 patients in the community are taking or have taken Interferon beta-1b SubQ Injection.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 437 | 82% |
| Other | 17 | 3% |
| Don't know | 6 | 1% |
| Fatigue | 6 | 1% |
| General health | 6 | 1% |
| Stiffness/spasticity | 4 | <1% |
| Difficulty walking | 3 | <1% |
| disease-related symptoms | 2 | <1% |
| Sexual dysfunction | 1 | <1% |
| Excessive daytime sleepiness (somnolence) | 1 | <1% |
| Bladder problems | 1 | <1% |
| Brain fog | 1 | <1% |
| Pain | 1 | <1% |
| Cognition | 1 | <1% |
| Vision | 1 | <1% |
| Headaches/ Migraines | 1 | <1% |
Based on the patients currently taking Interferon beta-1b SubQ Injection.
Top 10 (Show all)
All (Show Top 10)
| 0 mcg day | 0 mg day | 0 day | 0 mcg none | 0 mg none | 0 mL none | 0 mg week | 0.0178575 mg week | 0.021429 mg week | 0.03 mg day | 0.035715 mg week | 0.04 mg day | 0.042858 mg week | 0.075 mg day | 0.075 mg day | 0.125 mg day | 0.125 mcg day | 0.125 mg day | 0.128574 mg week | 0.14286 mg week | 0.149985 mg month | 0.15 mg none | 0.15 mg day | 0.15 mcg day | 0.15 mg day | 0.150003 mg week | 0.22 mg day | 0.25 mg day | 0.25 mg day | 0.25 day | 0.3 mg none | 0.3 mcg day | 0.3 mg day | 0.3 mg none | 0.375 mcg day | 0.375 mg day | 0.42858 mg week | 0.5 mg day | 0.5 g day | 0.5 mcg day | 0.5 mg day | 0.5 day | 0.57144 mg week | 0.65 mg day | 0.75 mg day | 0.9 mg week | 1 mg day | 1 mg day | 1.5 mg day | 2.1429 mg week | 2.5 mcg day | 3 mg day | 10 mg day | 10.5 mcg day | 12.5 mg day | 15 mg day | 18.85708 mcg week | 20 mcg day | 22 mcg day | 22 mg day | 42.858 mg week | 50 mcg day | 50 mg day | 100 mcg day | 100 mg day | 100 day | 125 mcg day | 125 mcg day | 125 mg day | 150 mg day | 250 mcg day | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
13
|
52
|
26
|
1
|
15
|
1
|
11
|
1
|
1
|
1
|
1
|
1
|
5
|
1
|
2
|
1
|
1
|
13
|
5
|
2
|
1
|
1
|
11
|
2
|
50
|
1
|
1
|
1
|
2
|
1
|
1
|
3
|
58
|
1
|
1
|
5
|
3
|
2
|
1
|
2
|
27
|
3
|
1
|
1
|
2
|
1
|
5
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
3
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
||
How long current patients have been taking Interferon beta-1b SubQ Injection or how long patients were taking Interferon beta-1b SubQ Injection before stopping.
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 58 | 39% | |
| Did not seem to work | 52 | 35% | |
| Doctor's advice | 47 | 32% | |
| Other | 34 | 23% | |
| Personal research | 4 | 3% | |
| Not indicated | 4 | 3% | |
| Course of treatment ended | 3 | 2% | |
| Expense | 1 | 1% |
Results from 36 patient evaluations. See the overall results and all individual evaluations.
| Major | 7% | 2 |
|---|---|---|
| Moderate | 10% | 3 |
| Slight | 20% | 6 |
| None | 20% | 6 |
| Can't tell | 43% | 13 |
Slow my MS progress
| Severe | 19% | 7 |
|---|---|---|
| Moderate | 31% | 11 |
| Mild | 39% | 14 |
| None | 11% | 4 |
Top reported side-effects include: flu like symtoms, Bruising, Depression
Summary results are based on 36 individual responses. For more information, see overall results for Adherence, Burden and Cost.
See all evaluation results for Interferon beta-1b SubQ Injection